Protara Therapeutics Inc Stock
Protara Therapeutics Inc Stock price
Key metrics
| Market capitalization | $38.78m |
| Enterprise Value | $-45.82m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 1.37 |
| P/B ratio (TTM) P/B ratio | 0.23 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-44.25m |
| Free Cash Flow (TTM) Free Cash Flow | $-33.42m |
| Cash position | $89.58m |
Is Protara Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.
Protara Therapeutics Inc Stock Analysis
Analyst Opinions
4 Analysts have issued a Protara Therapeutics Inc forecast:
Analyst Opinions
4 Analysts have issued a Protara Therapeutics Inc forecast:
Financial data from Protara Therapeutics Inc
| Jun '24 |
+/-
%
|
||
| Net Profit | -41 -41 |
39%
39%
|
|
| Depreciation and Amortization | 0.38 0.38 |
41%
41%
|
|
| Stock Compensation | 5.19 5.19 |
14%
14%
|
|
| Operating Cash Flow | -33 -33 |
2%
2%
|
|
| Investments | 0.09 0.09 |
10%
10%
|
|
| Dividend Paid | - - |
-
|
|
| Free Cash Flow | -33 -33 |
2%
2%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Protara Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Protara Therapeutics Inc Stock News
Company Profile
Protara Therapeutics, Inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is based in New York, New York.
| Head office | United States |
| CEO | Jesse Shefferman |
| Employees | 27 |
| Founded | 2006 |
| Website | www.protaratx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
